ftInvstr

GLAND · Healthcare ₹2939.7 -0.28% Mkt Cap ₹48549 Cr overvalued

GLAND

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹2939.7

-0.28% today · 30d +13.5%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for GLAND. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹1800 Cr

+19.57% YoY

NET PROFIT

₹317 Cr

+47.09% YoY

OPM

29.58%

+2.37pp YoY

EPS

₹19.23

PE 43.53

Intrinsic value · DCF ₹976.15 · Margin of safety -66.8% (overvalued) · FCF yield 1.11%

◇ Sector Position

PEERPEROCE %

GLAND43.5315.0

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 100

Valuation FAIR 40

Growth STRONG 83

Profitability HIGH 85

Technicals NEUTRAL 63

Risk LOW 90

Key Stats

TTM PE

43.53

P/B

4.73

52W HIGH

₹3039.8

OFF HIGH

-3.29%

DIV YIELD

0.68%

MKT CAP

₹48549 Cr

◉ Active Signals

MACDNeutral-8.0063

RSI(14)Bullish65.95

Near 52W HighBullish-3.29

Street Consensus

14 analysts

₹2856.07

mean target

Low ₹1940.0Now ₹2939.7High ₹3350.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold GLAND and at what entry.